NVO logo

Novo Nordisk A/S (NVO) Cash from operations

annual CFO:

$17.54B+$1.74B(+11.02%)
December 31, 2024

Summary

  • As of today (August 19, 2025), NVO annual cash flow from operations is $17.54 billion, with the most recent change of +$1.74 billion (+11.02%) on December 31, 2024.
  • During the last 3 years, NVO annual CFO has risen by +$8.80 billion (+100.68%).
  • NVO annual CFO is now at all-time high.

Performance

NVO Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

quarterly CFO:

$3.20B-$3.12B(-49.40%)
June 1, 2025

Summary

  • As of today (August 19, 2025), NVO quarterly cash flow from operations is $3.20 billion, with the most recent change of -$3.12 billion (-49.40%) on June 1, 2025.
  • Over the past year, NVO quarterly CFO has dropped by -$4.11 billion (-56.22%).
  • NVO quarterly CFO is now -56.22% below its all-time high of $7.31 billion, reached on June 30, 2024.

Performance

NVO quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

TTM CFO:

$17.68B-$4.11B(-18.86%)
June 1, 2025

Summary

  • As of today (August 19, 2025), NVO TTM cash flow from operations is $17.68 billion, with the most recent change of -$4.11 billion (-18.86%) on June 1, 2025.
  • Over the past year, NVO TTM CFO has increased by +$952.55 million (+5.70%).
  • NVO TTM CFO is now -18.86% below its all-time high of $21.78 billion, reached on March 31, 2025.

Performance

NVO TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

NVO Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+11.0%-56.2%+5.7%
3 y3 years+100.7%-6.5%+80.3%
5 y5 years+150.0%-10.6%+112.9%

NVO Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+100.7%-56.2%+283.6%-18.9%+82.1%
5 y5-yearat high+150.0%-56.2%+629.7%-18.9%+122.4%
alltimeall timeat high>+9999.0%-56.2%+629.7%-18.9%+7687.6%

NVO Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
$3.20B(-49.4%)
$17.68B(-18.9%)
Mar 2025
-
$6.33B(+271.4%)
$21.78B(+24.2%)
Dec 2024
$17.54B(+11.0%)
$1.70B(-73.6%)
$17.54B(+1.8%)
Sep 2024
-
$6.45B(-11.8%)
$17.23B(+3.0%)
Jun 2024
-
$7.31B(+250.8%)
$16.72B(+23.1%)
Mar 2024
-
$2.08B(+50.3%)
$13.59B(-14.0%)
Dec 2023
$15.80B(+41.8%)
$1.39B(-76.7%)
$15.80B(+3.6%)
Sep 2023
-
$5.94B(+42.3%)
$15.25B(+20.7%)
Jun 2023
-
$4.18B(-2.8%)
$12.64B(+6.3%)
Mar 2023
-
$4.30B(+415.1%)
$11.89B(+6.7%)
Dec 2022
$11.14B(+27.5%)
$834.40M(-74.9%)
$11.14B(+14.8%)
Sep 2022
-
$3.33B(-2.8%)
$9.71B(-1.0%)
Jun 2022
-
$3.42B(-3.7%)
$9.81B(-6.4%)
Mar 2022
-
$3.56B(-688.5%)
$10.47B(+19.8%)
Dec 2021
$8.74B(+10.0%)
-$604.25M(-117.6%)
$8.74B(-8.0%)
Sep 2021
-
$3.43B(-16.2%)
$9.50B(+7.9%)
Jun 2021
-
$4.09B(+124.5%)
$8.81B(+6.2%)
Mar 2021
-
$1.82B(+1080.6%)
$8.29B(+4.4%)
Dec 2020
$7.95B(+13.3%)
$154.46M(-94.4%)
$7.95B(-6.9%)
Sep 2020
-
$2.73B(-23.6%)
$8.54B(+2.8%)
Jun 2020
-
$3.58B(+142.3%)
$8.30B(+18.8%)
Mar 2020
-
$1.48B(+99.0%)
$6.99B(-0.4%)
Dec 2019
$7.02B(-0.7%)
$742.37M(-70.3%)
$7.02B(-4.9%)
Sep 2019
-
$2.50B(+10.3%)
$7.38B(+10.5%)
Jun 2019
-
$2.27B(+50.5%)
$6.68B(-3.8%)
Mar 2019
-
$1.51B(+36.1%)
$6.95B(-1.6%)
Dec 2018
$7.06B(+13.1%)
$1.11B(-38.6%)
$7.06B(+1.3%)
Sep 2018
-
$1.80B(-28.9%)
$6.97B(-2.7%)
Jun 2018
-
$2.53B(+56.3%)
$7.16B(+16.8%)
Mar 2018
-
$1.62B(+59.7%)
$6.13B(-1.8%)
Dec 2017
$6.25B(-13.0%)
$1.02B(-49.1%)
$6.25B(-8.9%)
Sep 2017
-
$1.99B(+32.7%)
$6.86B(-3.8%)
Jun 2017
-
$1.50B(-13.5%)
$7.13B(-8.8%)
Mar 2017
-
$1.74B(+6.8%)
$7.81B(+8.7%)
Dec 2016
$7.18B(+26.2%)
$1.63B(-28.1%)
$7.18B(+2.6%)
Sep 2016
-
$2.26B(+3.5%)
$7.00B(+6.3%)
Jun 2016
-
$2.19B(+97.3%)
$6.58B(+6.5%)
Mar 2016
-
$1.11B(-23.2%)
$6.18B(+8.6%)
Dec 2015
$5.69B(+0.9%)
$1.44B(-21.8%)
$5.69B(+4.4%)
Sep 2015
-
$1.84B(+3.3%)
$5.45B(-6.0%)
Jun 2015
-
$1.79B(+188.1%)
$5.80B(+5.3%)
Mar 2015
-
$619.60M(-48.6%)
$5.51B(-2.3%)
Dec 2014
$5.64B(+22.1%)
$1.20B(-45.1%)
$5.64B(+4.0%)
Sep 2014
-
$2.20B(+47.1%)
$5.42B(+25.2%)
Jun 2014
-
$1.49B(+99.8%)
$4.33B(+5.3%)
Mar 2014
-
$747.10M(-24.4%)
$4.11B(-10.9%)
Dec 2013
$4.62B(+20.5%)
$987.67M(-10.5%)
$4.62B(+18.7%)
Sep 2013
-
$1.10B(-13.5%)
$3.89B(-6.0%)
Jun 2013
-
$1.28B(+1.9%)
$4.14B(+7.1%)
Mar 2013
-
$1.25B(+380.0%)
$3.87B(+0.8%)
DateAnnualQuarterlyTTM
Dec 2012
$3.83B(-3.9%)
$260.73M(-80.7%)
$3.83B(-10.9%)
Sep 2012
-
$1.35B(+35.0%)
$4.30B(-2.1%)
Jun 2012
-
$1.00B(-17.9%)
$4.40B(+2.9%)
Mar 2012
-
$1.22B(+66.6%)
$4.27B(+7.1%)
Dec 2011
$3.99B(+14.1%)
$731.73M(-49.3%)
$3.99B(-3.3%)
Sep 2011
-
$1.44B(+64.9%)
$4.13B(+8.3%)
Jun 2011
-
$875.90M(-6.6%)
$3.81B(+4.3%)
Mar 2011
-
$937.58M(+8.1%)
$3.65B(+4.3%)
Dec 2010
$3.50B(+21.7%)
$867.00M(-23.1%)
$3.50B(+4.6%)
Sep 2010
-
$1.13B(+57.2%)
$3.35B(+5.6%)
Jun 2010
-
$717.46M(-8.7%)
$3.17B(+8.0%)
Mar 2010
-
$785.60M(+9.9%)
$2.93B(+2.0%)
Dec 2009
$2.87B(+12.4%)
$714.72M(-24.7%)
$2.87B(+5.6%)
Sep 2009
-
$949.38M(+96.6%)
$2.72B(+8.7%)
Jun 2009
-
$482.80M(-33.7%)
$2.51B(-6.1%)
Mar 2009
-
$728.01M(+29.3%)
$2.67B(+4.3%)
Dec 2008
$2.56B(+21.5%)
$562.97M(-23.1%)
$2.56B(-7.0%)
Sep 2008
-
$732.02M(+13.3%)
$2.75B(+3.6%)
Jun 2008
-
$646.02M(+4.7%)
$2.66B(+16.9%)
Mar 2008
-
$616.79M(-18.4%)
$2.27B(+8.0%)
Dec 2007
$2.10B(+61.6%)
$755.98M(+18.6%)
$2.10B(+47.6%)
Sep 2007
-
$637.37M(+142.4%)
$1.43B(+3.5%)
Jun 2007
-
$262.97M(-41.4%)
$1.38B(-2.6%)
Mar 2007
-
$448.54M(+481.8%)
$1.41B(+8.6%)
Dec 2006
$1.30B(-10.3%)
$77.09M(-86.9%)
$1.30B(-18.4%)
Sep 2006
-
$588.88M(+96.9%)
$1.60B(+6.8%)
Jun 2006
-
$299.11M(-11.3%)
$1.49B(-3.8%)
Mar 2006
-
$337.04M(-8.9%)
$1.55B(+6.9%)
Dec 2005
$1.45B(+14.6%)
$370.13M(-24.1%)
$1.45B(+1.2%)
Sep 2005
-
$487.60M(+36.2%)
$1.44B(+5.7%)
Jun 2005
-
$357.89M(+51.3%)
$1.36B(+6.3%)
Mar 2005
-
$236.51M(-33.0%)
$1.28B(+0.8%)
Dec 2004
$1.27B(+35.3%)
$353.14M(-13.8%)
$1.27B(+38.6%)
Sep 2004
-
$409.81M(+47.8%)
$914.09M(+81.3%)
Jun 2004
-
$277.31M(+22.2%)
$504.28M(+122.2%)
Mar 2004
-
$226.97M
$226.97M
Dec 2003
$936.74M(+51.2%)
-
-
Dec 2002
$619.40M(+19.4%)
-
-
Dec 2001
$518.58M(-20.2%)
-
-
Dec 2000
$649.61M(+25.3%)
-
-
Dec 1999
$518.49M(-0.1%)
-
-
Dec 1998
$518.92M(+13.4%)
-
-
Dec 1997
$457.50M(+38.3%)
-
-
Dec 1996
$330.82M(-26.8%)
-
-
Dec 1995
$452.11M(+32.3%)
-
-
Dec 1994
$341.63M(+16.2%)
-
-
Dec 1993
$294.01M(+33.2%)
-
-
Dec 1992
$220.78M(+19.3%)
-
-
Dec 1991
$185.05M(-24.0%)
-
-
Dec 1990
$243.33M(+79.8%)
-
-
Dec 1989
$135.33M
-
-

FAQ

  • What is Novo Nordisk A/S annual cash flow from operations?
  • What is the all time high annual CFO for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual CFO year-on-year change?
  • What is Novo Nordisk A/S quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly CFO year-on-year change?
  • What is Novo Nordisk A/S TTM cash flow from operations?
  • What is the all time high TTM CFO for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM CFO year-on-year change?

What is Novo Nordisk A/S annual cash flow from operations?

The current annual CFO of NVO is $17.54B

What is the all time high annual CFO for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual cash flow from operations is $17.54B

What is Novo Nordisk A/S annual CFO year-on-year change?

Over the past year, NVO annual cash flow from operations has changed by +$1.74B (+11.02%)

What is Novo Nordisk A/S quarterly cash flow from operations?

The current quarterly CFO of NVO is $3.20B

What is the all time high quarterly CFO for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly cash flow from operations is $7.31B

What is Novo Nordisk A/S quarterly CFO year-on-year change?

Over the past year, NVO quarterly cash flow from operations has changed by -$4.11B (-56.22%)

What is Novo Nordisk A/S TTM cash flow from operations?

The current TTM CFO of NVO is $17.68B

What is the all time high TTM CFO for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM cash flow from operations is $21.78B

What is Novo Nordisk A/S TTM CFO year-on-year change?

Over the past year, NVO TTM cash flow from operations has changed by +$952.55M (+5.70%)
On this page